Simplex Trading’s Kite Pharma, Inc. KITE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-2,145
Closed -$2.28M 7282
2017
Q3
$2.28M Buy
2,145
+1,726
+412% +$240K 0.09% 167
2017
Q2
$802K Sell
419
-331
-44% -$27K 0.03% 449
2017
Q1
$299K Buy
750
+405
+117% +$25K 0.01% 970
2016
Q4
$87K Sell
345
-214
-38% -$10.5K 0.01% 1658
2016
Q3
$86K Buy
559
+294
+111% +$16.4K 0.01% 1659
2016
Q2
$68K Buy
265
+103
+64% +$5.06K ﹤0.01% 1781
2016
Q1
$56K Sell
162
-71
-30% -$3.44K ﹤0.01% 1877
2015
Q4
$127K Buy
233
+98
+73% +$6.9K 0.01% 1176
2015
Q3
$31K Sell
135
-92
-41% -$5.79K ﹤0.01% 2374
2015
Q2
$142K Sell
227
-50
-18% -$2.85K 0.01% 994
2015
Q1
$163K Buy
277
+261
+1,631% +$17.5K 0.02% 817
2014
Q4
$25K Buy
+16
New +$674 ﹤0.01% 1895

Simplex Trading's KITE Position: Q4 2017 in Review

Simplex Trading sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 28,828 shares — an estimated $5.18M sold.

Simplex Trading first reported a position in KITE in Q4 2014 and held it in 5 quarters. The position peaked at $5.18M in Q3 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

  • Simplex Trading reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
  • Simplex Trading sold 28,828 Kite Pharma, Inc. shares in Q4 2017, an estimated $5.18M.
  • Simplex Trading first reported a position in Kite Pharma, Inc. in Q4 2014 and held it in 5 quarters.
  • Simplex Trading's Kite Pharma, Inc. position peaked at $5.18M in Q3 2017.
  • 0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on Simplex Trading's 13F filing for Q4 2017, filed 10 Jan 2018.